References
- Rutgeerts P, Geboes K, Vantrappen G et al. Predictability of the postoperative course of Crohn’s disease. Gastroenterology99, 956–963 (1990).
- Renna S, Cammà CM, Modesto I et al. Meta-analysis of the placebo rate of clinical relapse and severe endoscopic recurrence in post-operative Crohn’s disease. Gastroenterology135, 1500–1509 (2008).
- Cammà CM. Mesalamine and relapse prevention in Crohn’s disease. Gastroenterology119, 597 (2000).
- Cammà C, Viscido A, Latella G, Caprilli R, Cottone M. Mesalamine in the prevention of clinical and endoscopic post-operative recurrence of Crohn’s disease: a metaanalysis. Dig. Liver Dis.34, A86 (2002).
- Rutgeerts P, Van Assche G, Vermeire S et al. Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology128, 856–861 (2005).
- Rutgeerts P, Hiele M, Geboes K et al. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology108, 1617–1621 (1995).
- Hanauer S, Korelitz BI, Rutgeerts P et al. Postoperative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology127, 723–729 (2004).
- Ardizzone S, Maconi G, Sampietro GM et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery in Crohn’s disease. Gastroenterology127, 730–740 (2004).
- D’Haens G, Baert F, Van Assche G et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn’s disease: an open randomised trial. Lancet371, 660–667 (2008).
- Sorrentino D, Terrosu G, Avellini C et al. Prevention of post-operative recurrence of Crohn’s disease by infliximab. Arch. Intern. Med.167, 1804–1180 (2007).
- Regueiro M, Schraut W, Baidoo L. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology136, 441–450 (2009).
- D’Haens GR, Vermeire S, Van Assche G et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn’s disease: a controlled randomized trial. Gastroenterology135, 1123–1129 (2008).
- Wang R, Lagakos SW, Ware JH et al. Statistics in medicine – reporting of subgroup analyses in clinical trials. N. Engl. J. Med.357, 2189–2194 (2007).
- Caprilli R, Gassul MA, Escher JC et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations. Gut55(Suppl. I), I36–I58 (2006).
- Yamamoto T, Umegae S, Matsumoto K. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn’s disease: a prospective pilot study. Inflamm. Bowel Dis. DOI: 10.1002/ibd.20915 (2009) (Epub ahead of print).